In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.
D000347:Afibrinogenemia / Q000188:drug therapy*; D007611:Aprotinin / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D007700:Kinetics; D010958:Plasminogen / Q000037:antagonists & inhibitors*; D013300:Streptokinase / Q000037:antagonists & inhibitors*; D014361:Trypsin Inhibitors
D014361:Trypsin Inhibitors; D010958:Plasminogen; D007611:Aprotinin; D013300:Streptokinase; D005341:Fibrinolysin